Early pulmonary rehabilitation after acute exacerbation of COPD: A randomised controlled trial

Jakob L Kjærgaard, Carsten B Juhl, Peter Lange, Jon T Wilcke

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

33 Downloads (Pure)

Abstrakt

Objectives: The aim of this study was to establish whether early pulmonary rehabilitation after severe exacerbation of chronic obstructive pulmonary disease (COPD) reduces mortality and hospital admissions, and increases physical performance and quality of life compared to rehabilitation initiated later in the stable phase of COPD.

Methods: In a randomised controlled trial of 150 patients hospitalised with an exacerbation of COPD, participants were allocated to pulmonary rehabilitation either within 2 weeks after discharge or the same rehabilitation programme but initiated 2 months after discharge.

Results: Early pulmonary rehabilitation did not prolong time to first hospital admission or time to death (hazard ratio 0.79, 95% CI 0.47-1.23, p=0.33) compared to rehabilitation in stable phase. However, 2 months after inclusion, pulmonary rehabilitation resulted in a significantly better improvement in the incremental shuttle walk test (33.9 m, 95% CI 4.18-63.7, p=0.02) compared to that in the stable phase. The difference in the endurance shuttle walk test was of borderline significance (140 s, 95% CI -2.03-282.76, p=0.05), but there was no significant difference concerning the COPD assessment test (-1.43 points, 95% CI -3.44-0.59, p=0.17).

Conclusion: Early pulmonary rehabilitation after acute exacerbation of COPD led to a faster improvement in physical performance compared to rehabilitation initiated later in the stable phase, but did not improve survival or prolong time to hospital readmission.

OriginalsprogEngelsk
TidsskriftERJ Open Research
Vol/bind6
Udgave nummer1
ISSN2312-0541
DOI
StatusUdgivet - jan. 2020

Bibliografisk note

Copyright ©ERS 2020.

Fingeraftryk Dyk ned i forskningsemnerne om 'Early pulmonary rehabilitation after acute exacerbation of COPD: A randomised controlled trial'. Sammen danner de et unikt fingeraftryk.

Citationsformater